Loblaw Companies (TSE:L – Get Free Report) was upgraded by equities research analysts at Scotiabank to a “strong-buy” rating in a research report issued on Friday,Zacks.com reports.
L has been the subject of a number of other reports. Desjardins lifted their target price on Loblaw Companies from C$172.00 to C$190.00 in a research note on Thursday, November 14th. UBS Group set a C$225.00 price target on Loblaw Companies and gave the company a “buy” rating in a research report on Friday, December 13th. TD Securities cut their price target on shares of Loblaw Companies from C$203.00 to C$202.00 and set a “buy” rating for the company in a report on Thursday, November 14th. National Bankshares increased their price objective on Loblaw Companies from C$188.00 to C$195.00 in a research report on Thursday, November 14th. Finally, Royal Bank of Canada boosted their target price on Loblaw Companies from C$205.00 to C$217.00 and gave the stock an “outperform” rating in a research report on Monday, December 9th. One research analyst has rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Loblaw Companies has a consensus rating of “Buy” and a consensus price target of C$197.00.
Get Our Latest Report on Loblaw Companies
Loblaw Companies Trading Up 0.0 %
Insider Activity
In related news, Director Christie James Beckett Clark sold 2,105 shares of the company’s stock in a transaction on Wednesday, December 18th. The shares were sold at an average price of C$189.69, for a total value of C$399,297.45. 53.77% of the stock is owned by corporate insiders.
Loblaw Companies Company Profile
Loblaw is one of Canada’s largest grocery, pharmacy, and general merchandise retailers, operating the most expansive store footprint in Ontario and maintaining sizable presences in provinces like Quebec and British Columbia. Key grocery banners include Loblaw, No Frills, and Maxi, while its pharmaceutical operations are the product of its 2014 acquisition of Shoppers Drug Mart.
Recommended Stories
- Five stocks we like better than Loblaw Companies
- What is a support level?
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- What is the S&P 500 and How It is Distinct from Other Indexes
- Top 3 ETFs to Hedge Against Inflation in 2025
- The Most Important Warren Buffett Stock for Investors: His Own
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Loblaw Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Loblaw Companies and related companies with MarketBeat.com's FREE daily email newsletter.